Improving access to long-acting HIV prevention methods for young women in Africa
Scaling Comprehensively Access to Long-acting for an Effective Use of PrEP (SCALE-UP)
['FUNDING_R21'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-11006907
This study is looking at how to make it easier for young women and girls in Africa to use a long-lasting HIV prevention shot called cabotegravir, so they can stay healthy and safe from HIV.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11006907 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the implementation of long-acting injectable cabotegravir (CAB-LA) as a preventive measure against HIV among adolescent girls and young women in Africa. It aims to understand the real-world application of CAB-LA within Zambia's national HIV program, assessing factors that influence its uptake and effectiveness. By employing a rigorous implementation science approach, the study seeks to identify barriers and facilitators to accessing this innovative prevention method, ultimately aiming to improve health outcomes for at-risk populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women in Africa, particularly those at high risk for HIV.
Not a fit: Patients who are not at risk for HIV or those who do not reside in the targeted geographic areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV infection rates among adolescent girls and young women in Africa.
How similar studies have performed: Previous research has shown promising results with long-acting PrEP modalities in controlled settings, but this study aims to explore their effectiveness in real-world applications, making it a novel approach.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LAVOIE, MARIE-CLAUDE CAROLINE — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: LAVOIE, MARIE-CLAUDE CAROLINE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus